China-based Kexing Biopharm has entered into a comprehensive strategic partnership with IQVIA, a global leader...
Japan-based Solasia Pharma has entered into a licensing agreement with Firebird Biologics (headquartered in Singapore) g...
China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...
If there’s anything good to come from the tariff turmoil, it is that countries have rediscovered the importance of...
The Ministry of Health and Prevention (MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi...
Astria Therapeutics, Inc. a US-based biopharmaceutical company, has exclusively licensed development and commercial...
South Korea-based Celltrion, Inc. has announced that the US Food and Drug Administration (FDA) has approved an expanded ...
India-based Intas Pharmaceuticals, in collaboration with its global subsidiaries operating under the Accord brand, has s...
Everest Medicines, a China-based biopharmaceutical company focused on the discovery, clinical development, manufacturing...
Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...
Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialisin...
Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, has announced plans to construct a ...
The pharmaceutical and life sciences industry has been undergoing a transformation driven by rapid technological change,...
What are your plans for capacity expansion in biologics and ADC manufacturing? We are already among the largest biologi...
Presently, what are HSA’s key priorities that align with positioning Singapore as a regional hub for biotech and m...
Australian biotech is known for its cutting-edge research, robust clinical trial activity, and favourable R&D infras...
Global interest in radiopharmaceuticals has surged in recent years, driven by a string of high-profile deals and rising ...
